ES2131845T3 - Asociacion terapeutica vitamino-calcica en forma galenica unitaria de comprimidos, su procedimiento de obtencion y su utilizacion. - Google Patents

Asociacion terapeutica vitamino-calcica en forma galenica unitaria de comprimidos, su procedimiento de obtencion y su utilizacion.

Info

Publication number
ES2131845T3
ES2131845T3 ES95927758T ES95927758T ES2131845T3 ES 2131845 T3 ES2131845 T3 ES 2131845T3 ES 95927758 T ES95927758 T ES 95927758T ES 95927758 T ES95927758 T ES 95927758T ES 2131845 T3 ES2131845 T3 ES 2131845T3
Authority
ES
Spain
Prior art keywords
vitamino
calcica
unitary
tablets
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95927758T
Other languages
English (en)
Inventor
Catherine Meignant
Eric Stenger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9467219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2131845(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Application granted granted Critical
Publication of ES2131845T3 publication Critical patent/ES2131845T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

ESTA ASOCIACION TERAPEUTICA COMPRENDE COMO PRINCIPIOS ACTIVOS ASOCIADOS DEL CALCIO EN FORMA ELEMENTAL Y AL MENOS UNA VITAMINA D. CONTIENE ADEMAS AL MENOS UN LIGANTE EN SECO Y EN MEDIO HUMEDO COMBINADO EN CANTIDAD SINERGICA CON AL MENOS UN DILUYENTE, AL MENOS UN LIGANTE Y AL MENOS UN LUBRICANTE, SIENDO UNO AL MENOS DE DICHO DILUYENTE Y DE DICHO LIGANTE UN EDULCORANTE. VENTAJOSAMENTE, LA RELACION DEL CALCIO EN FORMA ELEMENTAL CON LA VITAMINA D, EXPRESADO EN MG DE CA ELEMENTO POR UI DE VITAMINA D, ESTA COMPRENDIDA ENTRE 1 Y 15, PREFERENTEMENTE ENTRE 1,2 Y 1,3.
ES95927758T 1994-09-23 1995-08-04 Asociacion terapeutica vitamino-calcica en forma galenica unitaria de comprimidos, su procedimiento de obtencion y su utilizacion. Expired - Lifetime ES2131845T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411381A FR2724844B1 (fr) 1994-09-23 1994-09-23 Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation

Publications (1)

Publication Number Publication Date
ES2131845T3 true ES2131845T3 (es) 1999-08-01

Family

ID=9467219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95927758T Expired - Lifetime ES2131845T3 (es) 1994-09-23 1995-08-04 Asociacion terapeutica vitamino-calcica en forma galenica unitaria de comprimidos, su procedimiento de obtencion y su utilizacion.

Country Status (18)

Country Link
EP (1) EP0785769B1 (es)
JP (1) JPH10505850A (es)
KR (1) KR100373393B1 (es)
AT (1) ATE177319T1 (es)
AU (1) AU3168395A (es)
CA (1) CA2200568C (es)
DE (1) DE69508263T2 (es)
DK (1) DK0785769T3 (es)
ES (1) ES2131845T3 (es)
FI (1) FI971188A (es)
FR (1) FR2724844B1 (es)
GR (1) GR3030266T3 (es)
HU (1) HU219597B (es)
NO (1) NO323814B1 (es)
OA (1) OA10336A (es)
PL (1) PL181340B1 (es)
RU (1) RU2154466C2 (es)
WO (1) WO1996009036A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716454B2 (en) 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
DE19639343C2 (de) 1996-09-25 1998-10-08 Suedzucker Ag Komprimate, enthaltend ein Süßungsmittelgemisch
DE19710054A1 (de) * 1997-03-12 1998-09-17 Merck Patent Gmbh Pharmazeutische Zubereitung
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable
FR2762217B1 (fr) * 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
FR2765804B1 (fr) * 1997-07-09 2003-10-10 Inst Pharma De Rech Applic Et Composition pharmaceutique d'apport calcique et formes galeniques orales comprenant une telle composition
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
CN1067250C (zh) * 1997-08-21 2001-06-20 中国人民解放军总装备部后勤部军事医学研究所 中性补钙制剂
FR2780861B1 (fr) * 1998-07-08 2000-09-08 Remy Laurenceau Composition pour volailles pondeuses contenant du l-pidolate de calcium
GB9825033D0 (en) 1998-11-13 1999-01-13 Nycomed Pharma As Process
RU2195269C2 (ru) * 2001-02-14 2002-12-27 Общество с ограниченной ответственностью "МДТ" Витаминно-минеральный комплекс
DE10317922B4 (de) * 2003-04-17 2009-11-26 Presearch Gmbh Verwendung eines Kombinationspräparates aus oralem Kontrazeptivum und Calcium/Vitamin D
KR100898970B1 (ko) 2004-05-24 2009-05-25 니코메드 파마 에이에스 칼슘-함유 화합물 및 당알코올을 포함하는 입상체
CN1997362B (zh) * 2004-06-01 2010-09-08 奈科明制药有限公司 包括含钙化合物作为活性物质的可咀嚼、可吮吸和可吞咽片剂
WO2006046111A1 (en) * 2004-10-26 2006-05-04 Nycomed Pharma As Use of xylitol as an anti-chalk acting agent in compositions for oral use containing a calcium-containing compound as an active substance
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
EP1845949B1 (en) 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
PL1861073T5 (pl) * 2005-03-04 2012-09-28 Takeda As Sposób wytwarzania kompozycji wapnia w złożu fluidalnym pracującym w sposób ciągły
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
CN101365426B (zh) 2005-12-07 2012-08-08 奈科明制药有限公司 预先压实的含钙组合物
KR100825572B1 (ko) 2006-08-30 2008-04-25 일양약품주식회사 칼슘, 마그네슘 및 비타민을 포함하는 액제 조성물 및 그의제조방법
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
MX2011004744A (es) 2008-11-17 2011-05-30 Nycomed Pharma As Estabilidad mejorada de disolucion de tabletas de carbonato de calcio.
CN107281216B (zh) * 2017-06-16 2020-05-05 北京济美堂医药研究有限公司 含钙化合物的药物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤

Also Published As

Publication number Publication date
HU219597B (hu) 2001-05-28
FR2724844A1 (fr) 1996-03-29
RU2154466C2 (ru) 2000-08-20
EP0785769A1 (fr) 1997-07-30
NO323814B1 (no) 2007-07-09
NO971356D0 (no) 1997-03-21
WO1996009036A1 (fr) 1996-03-28
KR100373393B1 (ko) 2003-05-16
HUT77702A (hu) 1998-07-28
DE69508263T2 (de) 1999-11-04
PL319585A1 (en) 1997-08-18
DE69508263D1 (de) 1999-04-15
FI971188A0 (fi) 1997-03-21
AU3168395A (en) 1996-04-09
CA2200568C (fr) 2008-10-28
ATE177319T1 (de) 1999-03-15
KR970705975A (ko) 1997-11-03
PL181340B1 (pl) 2001-07-31
GR3030266T3 (en) 1999-08-31
OA10336A (fr) 1997-10-07
DK0785769T3 (da) 1999-09-27
NO971356L (no) 1997-03-21
EP0785769B1 (fr) 1999-03-10
FI971188A (fi) 1997-05-20
FR2724844B1 (fr) 1997-01-24
JPH10505850A (ja) 1998-06-09
CA2200568A1 (fr) 1996-03-28

Similar Documents

Publication Publication Date Title
ES2131845T3 (es) Asociacion terapeutica vitamino-calcica en forma galenica unitaria de comprimidos, su procedimiento de obtencion y su utilizacion.
CA2251331A1 (en) Calcilytic compounds
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
FR2634376B1 (fr) Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
SE9700135D0 (sv) New formulation
ES8101381A1 (es) Un procedimiento para la obtencion de un aglutinante para los tejidos a base de proteinas humanas o animales
DK86389A (da) Farmaceutisk granulat
IE892285L (en) Use of polymeric compounds in treatment
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
SE8703631L (sv) For langsam avgivning anordnad fluorid- och kalciumkomposition
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
YU40398A (sh) Kompozicija nazalnog spreja za davanje sredstva za lečenje odloženog napada emezisa
ATE44467T1 (de) Fibrinolytisches mittel und diffusionsfaktor enthaltende pharmazeutische zusammensetzung verwendbar zur behandlung des myokardinfarktes.
ATE227981T1 (de) Captopriltabletten
USD336776S (en) Shoe outsole
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
AU5521099A (en) Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
EP0720849A3 (en) Agents for inhibiting the production of IL-1beta and the release of TNFalpha
RU98106378A (ru) Таблетки "леонирид" для лечения функциональных расстройств центральной и вегетативной нервной системы
RU96103806A (ru) Удобрительный состав
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
MX9800306A (es) Mezclas fungicidas.
RU97102782A (ru) Средство для терапии пародонтита

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 785769

Country of ref document: ES